Endogenous sex hormones and glucose tolerance status in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1289-1295

  Golden, Sherita Hill ^a,b   Dobs, Adrian S ^a   Vaidya, Dhananjay ^a   Szklo, Moyses ^b   Gapstur, Susan ^c   Kopp, Peter ^c   Liu, Kiang ^c   Ouyang, Pamela ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; PRASTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RATING SCALE;

EID: 34147130918     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1895     Document Type: Article

References (47)

1. Polderman KH, Gooren LJ, Asscheman H, Bakker A, Heine RJ 1994 Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271
2. Dunaif A 1993 Insulin resistance in polycystic ovarian syndrome. Ann NY Acad Sci 687:60-64
3. Lando J, Wynn V, Samols E 1963 The effect of anabolic steroids on blood sugar and plasma insulin levels in man. Metabolism 12:294-297
4. Diamond MP, Grainger D, Diamond MC, Sherwin RS, Defronzo RA 1998 Effects of methyltestosterone on insulin secretion and sensitivity in women. J Clin Endocrinol Metab 83:4420-4425
5. Larsson H, Ahren B 1996 Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Diabetes Care 19:1399-1403
6. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL 2002 Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25:55-60
7. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P 1994 Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411
8. Falkner B, Sherif K, Sumner A, Kushner H 1999 Hyperinsulinism and sex hormones in young adult African Americans. Metabolism 48:107-112
9. Maturana MA, Spritzer PM 2002 Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 51:238-243
10. Goodman-Gruen D, Barrett-Connor E 2000 Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23:912-918
11. Khaw KT, Barrett-Connor E 1991 Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin Sci (Lond) 80:199-203
12. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP 1993 Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 77:56-60
13. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Bjorntorp P 1991 Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 40:123-128
14. Ding EL, Song Y, Malik VS, Liu S 2006 Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288-1299
15. Haffner SM, Dunn JF, Katz MS 1992 Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 41:278-284
16. Goodman-Gruen D, Barrett-Connor E 1997 Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care 20:645-649
17. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A 2004 Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160:540-548
18. Phillips GB, Tuck CH, Jing TY, Boden-Albala, B, Lin, IF, Dahodwala, N, Sacco RL 2000 Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care 23:74-79
19. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI 2003 Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 88:1646-1652
20. Louet JF, LeMay C, Mauvais-Jarvis F 2004 Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6:180-185
21. Randolph Jr JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL 2003 Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88:1516-1522
22. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JI 2005 Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111:1242-1249
23. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob Jr DR, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP 2002 Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871-881
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
25. Hanley AJ, Williams K, Gonzalez C, D'Agostino Jr RB, Wagenknecht LE, Stern MP, Haffner SM 2003 Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463-469
26. Livingstone C, Collison M 2002 Sex steroids and insulin resistance. Clin Sci (Lond) 102:151-166
27. Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo M, Muggeo M 1996 The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81:952-960
28. Buffington CK, Kitabchi AE 1994 Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome. Metabolism 43:1367-1372
29. Gambineri A, Pagotto U, Tschop M, Vicennati V, Manicardi E, Carcello A, Cacciari M, De Iasio R, Pasquali R 2003 Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome. J Endocrinol Invest 26:629-634
30. Lovejoy JC, Bray GA, Bourgeois MO, Macchiavelli R, Rood JC, Greeson C, Partington C 1996 Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81:2198-2203
31. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL 1998 Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 21:1589-1595
32. Crespo CJ, Smit E, Snelling A, Sempos CT, Andersen RE 2002 Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 25:1675-1680
33. Saglam K, Polat Z, Yilmaz MI, Gulec M, Akinci SB 2002 Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 18:211-214
34. Li C, Samsioe G, Borgfeldt C, Bendahl PO, Wilawan K, Aberg A 2003 Low-dose hormone therapy and carbohydrate metabolism. Fertil Steril 79:550-555
35. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Bjorntorp P 1997 Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:638-643
36. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM 1997 Shortterm oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40:843-849
37. Friday KE, Dong C, Fontenot RU 2001 Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 86:48-52
38. Perera M, Sattar N, Petrie JR, Hillier C, Small M, Connell JM, Lowe GD, Lumsden MA 2001 The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. J Clin Endocrinol Metab 86:1140-1143
39. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E 2003 Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9
40. Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H, Tourniaire J 1991 Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 40:841-849
41. Haffner SM, Katz MS, Dunn JF 1991 Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 15:471-478
42. Labrie F, Luu-The V, Belanger A, Lin SX, Simard J, Pelletier G, Labrie C 2005 Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196
43. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F 1996 Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150(Suppl):S43-S50
44. Saruc M, Yuceyar H, Ayhan S, Turkel N, Tuzcuoglu I, Can M 2003 The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women-a hyperinsulinemic euglycemic insulin clamp study. Hepatogastroenterology 50:771-774
45. Key TJ, Chen J, Wang DY, Pike MC, Boreham J 1990 Sex hormones in women in rural China and in Britain. Br J Cancer 62:631-636
46. Cauley JA, Gutai JP, Kuller LH, Powell JG 1991 Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 133:50-57
47. Södergard R, Backstrom T, Shanbhag V, Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810